[Defibrillators--end of sudden cardiac death?]

Area of Science:

• Cardiology and Emergency Medicine
• Cardiac Electrophysiology
• Public Health

Context:

• Ventricular fibrillation (VF) remains the primary cause of sudden cardiac death (SCD), despite being known for over 150 years.
• High incidence of cardiac arrest in Europe (2500 daily), with 90% attributed to VF, highlighting a significant public health challenge.
• The critical time window for effective defibrillation is 3-8 minutes post-cardiac arrest.

Purpose:

• To review the current understanding and application of defibrillation technologies, including automated external defibrillators (AEDs) and implantable cardioverter-defibrillators (ICDs).
• To assess the effectiveness and current limitations of AEDs in out-of-hospital cardiac arrest scenarios.
• To evaluate the role of ICDs in both secondary and primary prevention of SCD in high-risk patients.

Summary:

• Automated external defibrillators (AEDs) have been used for 15 years, primarily in the USA, but their optimal deployment and impact on patient prognosis remain under investigation.
• Implantable cardioverter-defibrillators (ICDs) have demonstrated efficacy in reducing total mortality for secondary prevention (post-cardiac arrest) and primary prevention (patients with risk markers like left ventricle dysfunction).
• Studies like AVID, MUSTT, CIDS, MADIT I, and MADIT II have verified the benefits of ICDs in specific patient populations.

Impact:

• Defibrillation devices, while vital, do not eliminate the risk of sudden cardiac death.
• Significant reduction in SCD incidence is achievable through comprehensive prevention strategies, including lifestyle modifications and coronary artery disease (CAD) management.
• Future efforts must balance therapeutic interventions with robust primary prevention measures to further decrease SCD rates.